Reported Jul 19, 2023 · Ongoing
PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC,…
Vivus, Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Vivus, Inc. · 900 E Hamilton Ave Ste 550 · Campbell, CA · 95008-0643
Is this the product you have?
- PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008
- UPC
N3 62541-401-10 5NDC 62541-401-10
- Lot codes and dates
- Lot #: 102101
- Exp31 July 2024
- Amount recalled
- 4240 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Stability Specifications
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Vivus, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.